Glazer Capital LLC’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,502
| Closed | -$85K | – | 613 |
|
|
2022
Q3 | $85K | Buy |
8,502
+2,800
| +49% | +$28K | ﹤0.01% | 564 |
|
|
2022
Q2 | $56K | Buy |
5,702
+2,692
| +89% | +$26.4K | ﹤0.01% | 570 |
|
|
2022
Q1 | $30K | Buy |
+3,010
| New | +$30K | ﹤0.01% | 468 |
|
|
2021
Q4 | – | Sell |
-79,779
| Closed | -$791K | – | 967 |
|
|
2021
Q3 | $791K | Hold |
79,779
| – | – | 0.01% | 491 |
|
|
2021
Q2 | $814K | Sell |
79,779
-2,600
| -3% | -$26.5K | 0.01% | 536 |
|
|
2021
Q1 | $829K | Sell |
82,379
-143,306
| -63% | -$1.44M | 0.01% | 530 |
|
|
2020
Q4 | $2.41M | Buy |
+225,685
| New | +$2.41M | 0.09% | 204 |
|